BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 116.65M | 107.85M | 113.42M | 110.63M | 109.46M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | 17.10M | 21.52M | 22.44M | 19.26M | 20.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 99.54M | 86.33M | 90.98M | 91.37M | 88.66M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 73.83M | 57.87M | 58.58M | 52.91M | 45.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 45.25M | 48.49M | 44.88M | 41.02M | 41.04M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | 2.328M | 1.40M | 3.04M | -3.324M | 0.312M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 138.52M | 129.28M | 128.94M | 109.86M | 107.16M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -21.87M | -21.44M | -15.52M | 0.768M | 2.294M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -2.14M | -1.681M | -4.214M | -1.941M | -1.901M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -24.01M | -23.12M | -19.73M | -1.173M | 0.393M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | -0.034M | 3.619M | -2.078M | 3.904M | 4.764M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income after Tax | -23.97M | -26.74M | -17.65M | -5.077M | -4.371M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -23.97M | -26.74M | -17.65M | -5.077M | -4.371M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -23.97M | -26.74M | -17.65M | -5.077M | -4.371M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 115.07 | 112.12 | 112.29 | 111.11 | 110.74 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 115.07 | 112.12 | 112.29 | 111.11 | 110.65 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.21 | -0.23 | -0.16 | -0.05 | -0.04 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.21 | -0.23 | -0.16 | -0.05 | -0.04 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
